We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$4.86B
AUM Growth
+$848M
Cap. Flow
-$435M
Cap. Flow %
-8.93%
Top 10 Hldgs %
67.8%
Holding
712
New
128
Increased
53
Reduced
191
Closed
279

Top Buys

Rank Stock Value
1
PCGU
PG&E Corporation
PCGU
+$40.6M
2
SONY icon
Sony
SONY
+$35.3M
3
IMMU
Immunomedics Inc
IMMU
+$33.9M
4
JD icon
JD.com
JD
+$22.9M
5
MRNA icon
Moderna
MRNA
+$20.9M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$79.7M
2
CACC icon
Credit Acceptance
CACC
+$51.3M
3
CHL
China Mobile Limited
CHL
+$36M
4
INFY icon
Infosys
INFY
+$27.7M
5
RIO icon
Rio Tinto
RIO
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 5.97%
2 Consumer Discretionary 4.99%
3 Financials 3.45%
4 Healthcare 3.27%
5 Industrials 2.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEIC icon
251
SEI Investments
SEIC
$12.2B
$435K 0.01%
8,577
-1,514
-15% -$80K
CSL icon
252
Carlisle Companies
CSL
$13.8B
$434K 0.01%
3,546
-4,016
-53% -$493K
CTRA
253
DELISTED
Coterra Energy
CTRA
$434K 0.01%
24,975
-20,334
-45% -$380K
LPLA icon
254
LPL Financial
LPLA
$26.5B
$432K 0.01%
5,631
-994
-15% -$78.9K
MFG icon
255
Mizuho Financial
MFG
$129B
$420K 0.01%
168,942
-1,413,165
-89% -$3.71M
SRTAW
256
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$408K 0.01%
333,333
PCGU
257
DELISTED
PG&E Corporation
PCGU
$407K 0.01%
+415,000
New +$40.6M
BLFS icon
258
BioLife Solutions
BLFS
$1.46B
$402K 0.01%
13,904
ALL icon
259
Allstate
ALL
$67.3B
$401K 0.01%
+4,258
New +$397K
CEO
260
DELISTED
CNOOC Limited
CEO
$394K 0.01%
+4,100
New +$451K
KR icon
261
Kroger
KR
$35.5B
$391K 0.01%
11,517
-141,824
-92% -$4.9M
EG icon
262
Everest Group
EG
$15.4B
$388K 0.01%
1,963
+975
+99% +$209K
SSYS icon
263
Stratasys
SSYS
$700M
$380K 0.01%
30,492
-5,381
-15% -$78.5K
SCVX.WS
264
DELISTED
SCVX Corp.
SCVX.WS
$375K 0.01%
250,000
APH icon
265
Amphenol
APH
$184B
$373K 0.01%
+13,776
New +$363K
HRL icon
266
Hormel Foods
HRL
$14.3B
$370K 0.01%
7,571
-40,320
-84% -$2.02M
MTN icon
267
Vail Resorts
MTN
$5.28B
$369K 0.01%
1,725
-305
-15% -$62.9K
HSKA
268
DELISTED
Heska Corp
HSKA
$363K 0.01%
3,675
SCI icon
269
Service Corp International
SCI
$11.4B
$358K 0.01%
8,492
-13,927
-62% -$594K
TRMB icon
270
Trimble
TRMB
$13B
$350K 0.01%
7,196
-1,270
-15% -$60.7K
VIAV icon
271
Viavi Solutions
VIAV
$9.41B
$350K 0.01%
+29,867
New +$388K
GCP
272
DELISTED
GCP Applied Technologies Inc.
GCP
$350K 0.01%
16,710
-533
-3% -$12.3K
FLEX icon
273
Flex
FLEX
$42.5B
$340K 0.01%
40,472
-364,243
-90% -$2.97M
ABUS icon
274
Arbutus Biopharma
ABUS
$871M
$338K 0.01%
107,912
ELS icon
275
Equity Lifestyle Properties
ELS
$12.6B
$334K 0.01%
5,444
-961
-15% -$62.2K

Similar funds

LMR Partners's Q3 2020 Portfolio in Review

As of Q3 2020, LMR Partners held 712 positions worth $4.86B, up 21% from $4.02B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

LMR Partners withdrew a net $435M in Q3 2020, closing 279 positions and reducing 191 holdings. Its most notable exit was DuPont de Nemours, an estimated $79.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6% of assets, down from 9.2% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, LMR Partners opened a new position in PG&E Corporation worth $407K.

  • LMR Partners's largest Q3 2020 buy was PG&E Corporation: 415,000 shares worth $407K.
  • LMR Partners added most to Immunomedics Inc in Q3 2020, an estimated $33.9M increase.
  • LMR Partners's biggest Q3 2020 reduction was Infosys, cutting an estimated $27.7M.
  • LMR Partners fully exited DuPont de Nemours in Q3 2020, selling an estimated $79.7M.
  • LMR Partners's ten largest holdings make up 68% of its $4.86B portfolio in Q3 2020.
  • LMR Partners opened 128 new positions and closed 279 in Q3 2020.
  • LMR Partners's portfolio value rose 21% quarter-over-quarter to $4.86B.

Based on LMR Partners's 13F filing for Q3 2020, filed 16 Nov 2020.